Related Experiment Video
Updated: Jun 9, 2026

Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
Melatonin and childhood refractory epilepsy--a pilot study
Justyna Paprocka1, Renata Dec, Ewa Jamroz
1Child Neurology Department, Silesian Medical University, Katowice, Poland.
Insights
Children with refractory epilepsy show lower melatonin levels compared to healthy children. While the daily rhythm is maintained, a peak shift is observed in some epilepsy types, particularly in young children.
Area of Science:
- Pediatric Neurology
- Endocrinology
- Chronobiology
Background:
- Refractory epilepsy affects a significant number of children.
- Melatonin, a key hormone in circadian rhythm regulation, has been implicated in neurological disorders.
- Understanding melatonin secretion patterns in pediatric epilepsy is crucial for potential therapeutic interventions.
Purpose of the Study:
- To compare diurnal melatonin secretion in children with refractory epilepsy versus controls.
- To investigate differences in melatonin secretion between focal and generalized refractory epilepsy subtypes.
- To assess the impact of epilepsy on the daily rhythm and levels of melatonin.
Main Methods:
- Diurnal melatonin levels were measured every 3 hours in 74 children with refractory epilepsy and 37 controls.
- Participants were categorized into four subgroups: focal symptomatic, focal cryptogenic, generalized symptomatic, and generalized cryptogenic epilepsy.
- Radioimmunoassay (RIA) was used for melatonin level quantification.
Main Results:
- Children with refractory epilepsy exhibited significantly lower melatonin levels than the control group.
- The daily rhythm of melatonin secretion was preserved in the epilepsy cohort.
- A notable peak shift in melatonin secretion was observed in young children (6 months to 3 years) with generalized symptomatic refractory epilepsy.
Conclusions:
- Lowered melatonin levels in children with refractory epilepsy may be a consequence of the disease itself or influenced by antiepileptic drug treatments.
- The observed peak shift in specific subgroups suggests a potential disruption in circadian timing mechanisms.
- Further research is warranted to elucidate the precise relationship between melatonin, epilepsy, and treatment in pediatric populations.
Background:
The aim of the study was to assess diurnal melatonin secretion in children with refractory epilepsy (N=74) as compared to children without epileptic seizures (N=37) and to compare melatonin secretion in children with focal and generalized refractory epilepsy.
Material/Methods:
In the study group 4 subgroups were defined: children with focal symptomatic epilepsy, focal cryptogenic epilepsy, generalized symptomatic epilepsy, and generalized cryptogenic epilepsy. Melatonin level was measured every 3 hours using the RIA method.
Results:
Analysis of diurnal melatonin secretion indicated a lower level of the hormone in patients with refractory epilepsy. The daily rhythm of melatonin secretion in the study group was maintained, with a peak shift of melatonin secretion especially visible in the subgroup with generalized symptomatic refractory epilepsy in the age group between 6 months and 3 years of age.
Conclusions:
The hypothesis may be formed that a lowered level of melatonin in the study group in relation to the comparison group is the consequence of the natural course of epilepsy or is influenced by antiepileptic drugs.
Related Concept Videos
Management of Insomnia
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Narcolepsy
Nightmares and Night Terrors
Nightmares often...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
REM Sleep Behavior Disorder
RBD is significantly associated with...
